PCA3 and prostate carcinoma: Further, in combination with serum PSA (cut-off of 10 ng/mL) and urinary PCA3, T2-ERG provides an improved accuracy in diagnosing prostate cancer with a sensitivity and specificity of 80% and 90%, respectively [73].